NEW HORIZONS IN THE DIAGNOSIS OF VAGINITIS AND VAGINOSIS: MOLECULAR TECHNOLOGIES AND PROBIOTIC THERAPIES
Palavras-chave:
Clinical diagnosis, Gynecology, TreatmentResumo
Vaginal discharge remains one of the main gynecological complaints, characterized or not by associated symptoms such as leucorrhea, pruritus, dyspareunia, and unpleasant odor. However, due to excessive, unnecessary prescriptions and limited guidance on daily care, it is necessary to develop new diagnostic approaches, like propaedeutics, to prevent treatment resistance, which can render therapies ineffective when needed. Thus, the present study compiled information on the most up-to-date diagnostic methods for the treatment of vaginitis and vaginosis. Methodology: An integrative review was conducted using data from the PubMed and SciELO databases to identify studies on diagnostic techniques. Eleven articles were selected and analyzed according to inclusion and exclusion criteria. Results: Vaginitis caused by microorganisms such as Gardnerella vaginalis, Candida spp., and Trichomonas vaginalis is classified as specific. Vaginitis associated with imbalances in the vaginal microbiota, with proliferation of aerobic bacteria, is classified as nonspecific. Modern diagnostics include molecular methods, such as RT-PCR and NGS, which offer greater accuracy. The Immuno Quantex test assesses the local inflammatory response. Intravaginal devices containing hexylresorcinol and herbal extracts are effective in treating vaginal conditions. Probiotics, especially Lactobacillus crispatus, show promise in maintaining the microbiota and preventing infections, while new approaches to mixed vaginitis are under development to improve treatment and diagnostic efficacy. Conclusion: The combination of traditional treatments with new therapies, including probiotics and innovative medical devices, may provide a more comprehensive and effective solution for women experiencing recurrent vaginitis and other vaginal conditions.
Referências
ABOU CHACRA, L.; FENOLLAR, F.; DIOP, K. Bacterial Vaginosis: What Do We Currently Know? Frontiers in Cellular and Infection Microbiology, v. 11, Jan. 18, 2022.
ANDRADE, J. C. et al. Application of probiotics in the management of candidiasis. Critical Reviews in Food Science and Nutrition, v. 62, n. 30, p. 8249- 8264, 2022. DOI: https://doi.org/10.1080/10408398.2021.1926905
BUDILOVSKAYA, O. V. et al. Differential Expression of Local Immune Response Genes in the Vagina: Implication for the Diagnosis of Vaginal Infections. Bulletin of Experimental Biology and Medicine, v. 168, n. 5, p. 646–650, Mar. 1, 2020.
CARVALHO, N. S. et al. Brazilian Protocol for Sexually Transmitted Infections 2020: infections that cause vaginal discharge. Epidemiology and Health Services, v. 30, n. spe1, 2021.
TOADER, D. O. et al. Clinical Performance and Safety of Vaginal Ovules in the Local Treatment of Nonspecific Vaginitis: A National, Multicentric Clinical Investigation. Clinical Therapeutics, July 1, 2023.
FEBRASGO - Brazilian Federation of Gynecology and Obstetrics Associations - Gynecology Protocol No. 24: Vaginitis and Vaginosis. São Paulo, 2018.
KISSINGER, P. J. et al. Diagnosis and Management of Trichomonas vaginalis: Summary of Evidence Reviewed for the 2021 Centers for Disease Control and Prevention Sexually Transmitted Infections Treatment Guidelines. Clinical Infectious Diseases, v. 74, n. Supplement_2, p. S152–S161, Apr. 13, 2022.
LINHARES, I. et al. Vaginitis and vaginosis. | 235 FEMINA, v. 47, n. 4, p. 235–275, 2019.
MERCHÁN-VILLAFUERTE, K.M. et al. Application of the Amsel and Nugent criteria in Ecuadorian women with bacterial vaginosis. Polo del Conocimiento, v. 5, n. 6, p. 874, 2020.
SAVICHEVA, A. M. Molecular Testing for the Diagnosis of Bacterial Vaginosis. International Journal of Molecular Sciences, v. 25, n. 1, p. 449–449, Dec. 28, 2023.
ZHENG, N. et al. Contribution of Lactobacillus iners to Vaginal Health and Diseases: A Systematic Review. Frontiers in Cellular and Infection Microbiology, v. 11, Nov. 22, 2021.
